InvestorsHub Logo
Followers 30
Posts 5059
Boards Moderated 0
Alias Born 01/07/2020

Re: marjac post# 284540

Saturday, 07/04/2020 2:36:56 PM

Saturday, July 04, 2020 2:36:56 PM

Post# of 426304
marjac@

Board of Directors, and attorneys knew or should have known that Amarin's intellectual property was vulnerable to attack, and likewise knew or should have known that devastation to the company and shareholders would ensue if those vulnerabilities were exposed, it is difficult to discern anything that would be commercially worse than what happened on 3/30.


Being a lay person in law - I dont belong in these legal debates - but I just have to acknowledge the power of the above statement.

Only thing I do have to add. I personally have newer 'been more sure of an investment' than AMRN after 0-16 Adcom and label Approval december 2019.

At that time 'no one was even considering Patent case to be 'a real threat' to Amarin. John Thero stated on CNBC that 'everything under control': "We trust our Patents".

https://www.cnbc.com/video/2019/12/16/amarin-ceo-on-fdas-approval-of-key-heart-drug.html

Truth is we all 'felt 98% sure' that the road 'Was Clear' for Amarin - no one (retailers) really felt that 'the Patent Case' - was something that could be a real threat to the succes of Vascepa.

But the market clearly 'did not like it' - making the SP all the time 'slide back' - as day of ruling aproched.
----------------------------

What I hear you saying here is'- that the Pro's in this game should have been able to 'weigh in' on the devastating damage a possible loss would be to this One Drug Company - and then have 'made sure' that this 'risk of total downfall' was removed.

Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News